Fundraising FoxCitta Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.
HealthtechMiami Lakes, US
Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)
BoardWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)
PartnerJim Mao· solo GP
Co-investorsCEI VenturesF-Prime CapitalFounder CollectiveFunction VenturesHelios Digital VenturesLifeX Ventures+4 more
Kamiwaza offers a distributed AI orchestration platform that processes data where it resides, allowing enterprises to deploy AI without centralizing data or compromising security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareGovTechSilverthorne, US
Matthew Wallace(Executive Officer, Director)inLuke Matthew Norris(Executive Officer, Director)
PartnerJim Mao· solo GP
Co-investorsAscend Venture CapitalFirstMile VenturesGreater Colorado Venture FundPioneer Square LabsS3 VenturesAscend+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.